Following ICS/LABA treatment in the PTlow with BPD group, levels of DSG1, DSC1 and JUP were comparable to the term control group at baseline (p = 0.56, 0.12, 0.06 respectively). The gene discussed is DSG1; the disease is bronchopulmonary dysplasia.